Gene · 1213
NIH grants2,119
NIH grants whose papers are about the gene, through NIH's grant-paper links.
441 to 460 of 2,119
Download this page as JSON| Grant | Title | CLTC papers | Newest fiscal year |
|---|---|---|---|
| R01NS093653 | Evaluation of Small-Fiber Polyneuropathy in Youth | 1 | 2024 |
| R01NS110810 | Role of Ankyrin-B in the Nervous System | 1 | 2024 |
| R15CA260126 | PA-23-189 for Kaya Johnson to CA260126-01: Identifying a proteomic signature for breast cancer detection in breast milk and serum | 1 | 2024 |
| R35GM122568 | Molecular mechanisms of ARF family GTPases | 1 | 2024 |
| R35GM136428 | Functional causality in regulating cell morphogenesis | 1 | 2024 |
| R35GM138184 | Functional annotation of new genes aided by deep learning | 1 | 2024 |
| R35GM138214 | Interrogation and interpretation of protein kinase signaling dynamics at single-cell resolution | 1 | 2024 |
| R37CA218707 | Unmet needs for specific subsets of EGFR mutated lung cancer | 1 | 2024 |
| R61NS126792 | Consortium Of MRI Biomarkers In Neonatal Encephalopathy (COMBINE) | 1 | 2024 |
| RF1NS078165 | Mechanisms of Synaptic Dysfunction in Parkinson's and Other Synuclein-Linked Diseases | 1 | 2024 |
| SC1GM139727 | miR-205 Nanoparticle system circumvents docetaxel resistance in prostate cancer | 1 | 2024 |
| T32AI007151 | Infectious Disease Pathogenesis Research Training Program | 1 | 2024 |
| T32AT004094 | Botanical Approaches to Combat Metabolic Syndrome | 1 | 2024 |
| T32CA009140 | Immunobiology of Normal and Neoplastic Lymphocytes | 1 | 2024 |
| T32CA009666 | Research Training in Academic Medical Oncology | 1 | 2024 |
| T32CA108462 | Molecular and Cellular Mechanisms in Cancer | 1 | 2024 |
| TL1TR001451 | NRSA Training Core | 1 | 2024 |
| U01CA243004 | Multiscale analysis of metabolic inflammation as a driver of breast cancer | 1 | 2024 |
| U01CA252965 | Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples | 1 | 2024 |
| U54AG062319 | Bioenergetic and Cardiometabolic Consequences of the Loss of Gonadal Function | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1213/grants?page=23